共 50 条
- [7] TERIFLUNOMIDE: NEW ORAL IMMUNMODULANT DRUG IN THERAPY OF MULTIPLE SCLEROSIS [J]. IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2015, 68 (3-4): : 79 - 87
- [9] Ofatumumab versus Teriflunomide in Multiple Sclerosis [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (06): : 546 - 557